 | • レポートコード：MRC2Q12-16798 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、塩酸メマンチン持続放出カプセルの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に塩酸メマンチン持続放出カプセルのグローバル市場のxxx％を占める「7mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「家庭」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 塩酸メマンチン持続放出カプセルの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの塩酸メマンチン持続放出カプセル市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 塩酸メマンチン持続放出カプセルのグローバル主要プレイヤーには、Lundbeck、Allergan、Novartis AG、Lupin Ltd、Huahai Pharmaceutical、Daiichi Sankyo Company Limited、Rottendorf Pharma GmbH、Polygen Pharms、Macleods Pharms Ltd、Amneal Pharms、Apeloa Pharmaceutical、HUMANWELL GROUP、Eisai Co、Ono Pharmaceutical Co Ltd、Slate Runなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 塩酸メマンチン持続放出カプセル市場は、種類と用途によって区分されます。世界の塩酸メマンチン持続放出カプセル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 7mg、14mg、21mg、28mg、その他 【用途別セグメント】 家庭、病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 塩酸メマンチン持続放出カプセル製品概要 - 種類別市場（7mg、14mg、21mg、28mg、その他） - 用途別市場（家庭、病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の塩酸メマンチン持続放出カプセル販売量予測2017-2028 - 世界の塩酸メマンチン持続放出カプセル売上予測2017-2028 - 塩酸メマンチン持続放出カプセルの地域別販売量 - 塩酸メマンチン持続放出カプセルの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別塩酸メマンチン持続放出カプセル販売量 - 主要メーカー別塩酸メマンチン持続放出カプセル売上 - 主要メーカー別塩酸メマンチン持続放出カプセル価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（7mg、14mg、21mg、28mg、その他） - 塩酸メマンチン持続放出カプセルの種類別販売量 - 塩酸メマンチン持続放出カプセルの種類別売上 - 塩酸メマンチン持続放出カプセルの種類別価格 ・用途別市場規模（家庭、病院、診療所、その他） - 塩酸メマンチン持続放出カプセルの用途別販売量 - 塩酸メマンチン持続放出カプセルの用途別売上 - 塩酸メマンチン持続放出カプセルの用途別価格 ・北米市場 - 北米の塩酸メマンチン持続放出カプセル市場規模（種類別、用途別） - 主要国別の塩酸メマンチン持続放出カプセル市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの塩酸メマンチン持続放出カプセル市場規模（種類別、用途別） - 主要国別の塩酸メマンチン持続放出カプセル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の塩酸メマンチン持続放出カプセル市場規模（種類別、用途別） - 主要国別の塩酸メマンチン持続放出カプセル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の塩酸メマンチン持続放出カプセル市場規模（種類別、用途別） - 主要国別の塩酸メマンチン持続放出カプセル市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの塩酸メマンチン持続放出カプセル市場規模（種類別、用途別） - 主要国別の塩酸メマンチン持続放出カプセル市場規模（トルコ、サウジアラビア） ・企業情報 Lundbeck、Allergan、Novartis AG、Lupin Ltd、Huahai Pharmaceutical、Daiichi Sankyo Company Limited、Rottendorf Pharma GmbH、Polygen Pharms、Macleods Pharms Ltd、Amneal Pharms、Apeloa Pharmaceutical、HUMANWELL GROUP、Eisai Co、Ono Pharmaceutical Co Ltd、Slate Run ・産業チェーン及び販売チャネル分析 - 塩酸メマンチン持続放出カプセルの産業チェーン分析 - 塩酸メマンチン持続放出カプセルの原材料 - 塩酸メマンチン持続放出カプセルの生産プロセス - 塩酸メマンチン持続放出カプセルの販売及びマーケティング - 塩酸メマンチン持続放出カプセルの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 塩酸メマンチン持続放出カプセルの産業動向 - 塩酸メマンチン持続放出カプセルのマーケットドライバー - 塩酸メマンチン持続放出カプセルの課題 - 塩酸メマンチン持続放出カプセルの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Memantine Hydrochloride Extended-Release Capsule estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Memantine Hydrochloride Extended-Release Capsule is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Memantine Hydrochloride Extended-Release Capsule is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Memantine Hydrochloride Extended-Release Capsule is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Memantine Hydrochloride Extended-Release Capsule include Lundbeck, Allergan, Novartis AG, Lupin Ltd, Huahai Pharmaceutical, Daiichi Sankyo Company Limited, Rottendorf Pharma GmbH, Polygen Pharms and Macleods Pharms Ltd, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Memantine Hydrochloride Extended-Release Capsule companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Memantine Hydrochloride Extended-Release Capsule market. Further, it explains the major drivers and regional dynamics of the global Memantine Hydrochloride Extended-Release Capsule market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Lundbeck
Allergan
Novartis AG
Lupin Ltd
Huahai Pharmaceutical
Daiichi Sankyo Company Limited
Rottendorf Pharma GmbH
Polygen Pharms
Macleods Pharms Ltd
Amneal Pharms
Apeloa Pharmaceutical
HUMANWELL GROUP
Eisai Co
Ono Pharmaceutical Co Ltd
Slate Run
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Memantine Hydrochloride Extended-Release Capsule Segment by Type
7mg
14mg
21mg
28mg
Others
Memantine Hydrochloride Extended-Release Capsule Segment by Application
Home
Hospital
Clinic
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Memantine Hydrochloride Extended-Release Capsule market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Memantine Hydrochloride Extended-Release Capsule market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Memantine Hydrochloride Extended-Release Capsule, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Memantine Hydrochloride Extended-Release Capsule, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Memantine Hydrochloride Extended-Release Capsule revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Memantine Hydrochloride Extended-Release Capsule market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Memantine Hydrochloride Extended-Release Capsule revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lundbeck, Allergan, Novartis AG, Lupin Ltd, Huahai Pharmaceutical, Daiichi Sankyo Company Limited, Rottendorf Pharma GmbH, Polygen Pharms and Macleods Pharms Ltd, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Memantine Hydrochloride Extended-Release Capsule in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Memantine Hydrochloride Extended-Release Capsule companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Memantine Hydrochloride Extended-Release Capsule revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 7mg
1.2.3 14mg
1.2.4 21mg
1.2.5 28mg
1.2.6 Others
1.3 Market by Application
1.3.1 Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Home
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Perspective (2017-2028)
2.2 Memantine Hydrochloride Extended-Release Capsule Growth Trends by Region
2.2.1 Memantine Hydrochloride Extended-Release Capsule Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Region (2017-2022)
2.2.3 Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Region (2023-2028)
2.3 Memantine Hydrochloride Extended-Release Capsule Market Dynamics
2.3.1 Memantine Hydrochloride Extended-Release Capsule Industry Trends
2.3.2 Memantine Hydrochloride Extended-Release Capsule Market Drivers
2.3.3 Memantine Hydrochloride Extended-Release Capsule Market Challenges
2.3.4 Memantine Hydrochloride Extended-Release Capsule Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Memantine Hydrochloride Extended-Release Capsule Players by Revenue
3.1.1 Global Top Memantine Hydrochloride Extended-Release Capsule Players by Revenue (2017-2022)
3.1.2 Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Players (2017-2022)
3.2 Global Memantine Hydrochloride Extended-Release Capsule Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Memantine Hydrochloride Extended-Release Capsule Revenue
3.4 Global Memantine Hydrochloride Extended-Release Capsule Market Concentration Ratio
3.4.1 Global Memantine Hydrochloride Extended-Release Capsule Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Memantine Hydrochloride Extended-Release Capsule Revenue in 2021
3.5 Memantine Hydrochloride Extended-Release Capsule Key Players Head office and Area Served
3.6 Key Players Memantine Hydrochloride Extended-Release Capsule Product Solution and Service
3.7 Date of Enter into Memantine Hydrochloride Extended-Release Capsule Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Memantine Hydrochloride Extended-Release Capsule Breakdown Data by Type
4.1 Global Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Type (2017-2022)
4.2 Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Type (2023-2028)
5 Memantine Hydrochloride Extended-Release Capsule Breakdown Data by Application
5.1 Global Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Application (2017-2022)
5.2 Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Memantine Hydrochloride Extended-Release Capsule Market Size (2017-2028)
6.2 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Type
6.2.1 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2017-2022)
6.2.2 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2023-2028)
6.2.3 North America Memantine Hydrochloride Extended-Release Capsule Market Share by Type (2017-2028)
6.3 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Application
6.3.1 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2017-2022)
6.3.2 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2023-2028)
6.3.3 North America Memantine Hydrochloride Extended-Release Capsule Market Share by Application (2017-2028)
6.4 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country
6.4.1 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2017-2022)
6.4.2 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Memantine Hydrochloride Extended-Release Capsule Market Size (2017-2028)
7.2 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Type
7.2.1 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2017-2022)
7.2.2 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2023-2028)
7.2.3 Europe Memantine Hydrochloride Extended-Release Capsule Market Share by Type (2017-2028)
7.3 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Application
7.3.1 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2017-2022)
7.3.2 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2023-2028)
7.3.3 Europe Memantine Hydrochloride Extended-Release Capsule Market Share by Application (2017-2028)
7.4 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country
7.4.1 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2017-2022)
7.4.2 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size (2017-2028)
8.2 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Type
8.2.1 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Share by Type (2017-2028)
8.3 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Application
8.3.1 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Share by Application (2017-2028)
8.4 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region
8.4.1 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size (2017-2028)
9.2 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Type
9.2.1 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2017-2022)
9.2.2 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2023-2028)
9.2.3 Latin America Memantine Hydrochloride Extended-Release Capsule Market Share by Type (2017-2028)
9.3 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Application
9.3.1 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2017-2022)
9.3.2 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2023-2028)
9.3.3 Latin America Memantine Hydrochloride Extended-Release Capsule Market Share by Application (2017-2028)
9.4 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country
9.4.1 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2017-2022)
9.4.2 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size (2017-2028)
10.2 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Type
10.2.1 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Share by Type (2017-2028)
10.3 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Application
10.3.1 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Share by Application (2017-2028)
10.4 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country
10.4.1 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lundbeck
11.1.1 Lundbeck Company Details
11.1.2 Lundbeck Business Overview
11.1.3 Lundbeck Memantine Hydrochloride Extended-Release Capsule Introduction
11.1.4 Lundbeck Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.1.5 Lundbeck Recent Developments
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Memantine Hydrochloride Extended-Release Capsule Introduction
11.2.4 Allergan Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.2.5 Allergan Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Memantine Hydrochloride Extended-Release Capsule Introduction
11.3.4 Novartis AG Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.3.5 Novartis AG Recent Developments
11.4 Lupin Ltd
11.4.1 Lupin Ltd Company Details
11.4.2 Lupin Ltd Business Overview
11.4.3 Lupin Ltd Memantine Hydrochloride Extended-Release Capsule Introduction
11.4.4 Lupin Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.4.5 Lupin Ltd Recent Developments
11.5 Huahai Pharmaceutical
11.5.1 Huahai Pharmaceutical Company Details
11.5.2 Huahai Pharmaceutical Business Overview
11.5.3 Huahai Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.5.4 Huahai Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.5.5 Huahai Pharmaceutical Recent Developments
11.6 Daiichi Sankyo Company Limited
11.6.1 Daiichi Sankyo Company Limited Company Details
11.6.2 Daiichi Sankyo Company Limited Business Overview
11.6.3 Daiichi Sankyo Company Limited Memantine Hydrochloride Extended-Release Capsule Introduction
11.6.4 Daiichi Sankyo Company Limited Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.6.5 Daiichi Sankyo Company Limited Recent Developments
11.7 Rottendorf Pharma GmbH
11.7.1 Rottendorf Pharma GmbH Company Details
11.7.2 Rottendorf Pharma GmbH Business Overview
11.7.3 Rottendorf Pharma GmbH Memantine Hydrochloride Extended-Release Capsule Introduction
11.7.4 Rottendorf Pharma GmbH Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.7.5 Rottendorf Pharma GmbH Recent Developments
11.8 Polygen Pharms
11.8.1 Polygen Pharms Company Details
11.8.2 Polygen Pharms Business Overview
11.8.3 Polygen Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.8.4 Polygen Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.8.5 Polygen Pharms Recent Developments
11.9 Macleods Pharms Ltd
11.9.1 Macleods Pharms Ltd Company Details
11.9.2 Macleods Pharms Ltd Business Overview
11.9.3 Macleods Pharms Ltd Memantine Hydrochloride Extended-Release Capsule Introduction
11.9.4 Macleods Pharms Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.9.5 Macleods Pharms Ltd Recent Developments
11.10 Amneal Pharms
11.10.1 Amneal Pharms Company Details
11.10.2 Amneal Pharms Business Overview
11.10.3 Amneal Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.10.4 Amneal Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.10.5 Amneal Pharms Recent Developments
11.11 Apeloa Pharmaceutical
11.11.1 Apeloa Pharmaceutical Company Details
11.11.2 Apeloa Pharmaceutical Business Overview
11.11.3 Apeloa Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.11.4 Apeloa Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.11.5 Apeloa Pharmaceutical Recent Developments
11.12 HUMANWELL GROUP
11.12.1 HUMANWELL GROUP Company Details
11.12.2 HUMANWELL GROUP Business Overview
11.12.3 HUMANWELL GROUP Memantine Hydrochloride Extended-Release Capsule Introduction
11.12.4 HUMANWELL GROUP Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.12.5 HUMANWELL GROUP Recent Developments
11.13 Eisai Co
11.13.1 Eisai Co Company Details
11.13.2 Eisai Co Business Overview
11.13.3 Eisai Co Memantine Hydrochloride Extended-Release Capsule Introduction
11.13.4 Eisai Co Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.13.5 Eisai Co Recent Developments
11.14 Ono Pharmaceutical Co Ltd
11.14.1 Ono Pharmaceutical Co Ltd Company Details
11.14.2 Ono Pharmaceutical Co Ltd Business Overview
11.14.3 Ono Pharmaceutical Co Ltd Memantine Hydrochloride Extended-Release Capsule Introduction
11.14.4 Ono Pharmaceutical Co Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.14.5 Ono Pharmaceutical Co Ltd Recent Developments
11.15 Slate Run
11.15.1 Slate Run Company Details
11.15.2 Slate Run Business Overview
11.15.3 Slate Run Memantine Hydrochloride Extended-Release Capsule Introduction
11.15.4 Slate Run Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
11.15.5 Slate Run Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of 7mg
Table 3. Key Players of 14mg
Table 4. Key Players of 21mg
Table 5. Key Players of 28mg
Table 6. Key Players of Others
Table 7. Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2017-2022)
Table 11. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2023-2028)
Table 13. Memantine Hydrochloride Extended-Release Capsule Market Trends
Table 14. Memantine Hydrochloride Extended-Release Capsule Market Drivers
Table 15. Memantine Hydrochloride Extended-Release Capsule Market Challenges
Table 16. Memantine Hydrochloride Extended-Release Capsule Market Restraints
Table 17. Global Memantine Hydrochloride Extended-Release Capsule Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Memantine Hydrochloride Extended-Release Capsule Revenue Share by Players (2017-2022)
Table 19. Global Top Memantine Hydrochloride Extended-Release Capsule by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Memantine Hydrochloride Extended-Release Capsule as of 2021)
Table 20. Ranking of Global Top Memantine Hydrochloride Extended-Release Capsule Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Memantine Hydrochloride Extended-Release Capsule Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Memantine Hydrochloride Extended-Release Capsule Product Solution and Service
Table 24. Date of Enter into Memantine Hydrochloride Extended-Release Capsule Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Type (2017-2022)
Table 28. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Type (2023-2028)
Table 30. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Memantine Hydrochloride Extended-Release Capsule Revenue Share by Application (2017-2022)
Table 32. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Memantine Hydrochloride Extended-Release Capsule Revenue Share by Application (2023-2028)
Table 34. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2023-2028) & (US$ Million)
Table 64. Lundbeck Company Details
Table 65. Lundbeck Business Overview
Table 66. Lundbeck Memantine Hydrochloride Extended-Release Capsule Product
Table 67. Lundbeck Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 68. Lundbeck Recent Developments
Table 69. Allergan Company Details
Table 70. Allergan Business Overview
Table 71. Allergan Memantine Hydrochloride Extended-Release Capsule Product
Table 72. Allergan Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 73. Allergan Recent Developments
Table 74. Novartis AG Company Details
Table 75. Novartis AG Business Overview
Table 76. Novartis AG Memantine Hydrochloride Extended-Release Capsule Product
Table 77. Novartis AG Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 78. Novartis AG Recent Developments
Table 79. Lupin Ltd Company Details
Table 80. Lupin Ltd Business Overview
Table 81. Lupin Ltd Memantine Hydrochloride Extended-Release Capsule Product
Table 82. Lupin Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 83. Lupin Ltd Recent Developments
Table 84. Huahai Pharmaceutical Company Details
Table 85. Huahai Pharmaceutical Business Overview
Table 86. Huahai Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 87. Huahai Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 88. Huahai Pharmaceutical Recent Developments
Table 89. Daiichi Sankyo Company Limited Company Details
Table 90. Daiichi Sankyo Company Limited Business Overview
Table 91. Daiichi Sankyo Company Limited Memantine Hydrochloride Extended-Release Capsule Product
Table 92. Daiichi Sankyo Company Limited Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 93. Daiichi Sankyo Company Limited Recent Developments
Table 94. Rottendorf Pharma GmbH Company Details
Table 95. Rottendorf Pharma GmbH Business Overview
Table 96. Rottendorf Pharma GmbH Memantine Hydrochloride Extended-Release Capsule Product
Table 97. Rottendorf Pharma GmbH Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 98. Rottendorf Pharma GmbH Recent Developments
Table 99. Polygen Pharms Company Details
Table 100. Polygen Pharms Business Overview
Table 101. Polygen Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 102. Polygen Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 103. Polygen Pharms Recent Developments
Table 104. Macleods Pharms Ltd Company Details
Table 105. Macleods Pharms Ltd Business Overview
Table 106. Macleods Pharms Ltd Memantine Hydrochloride Extended-Release Capsule Product
Table 107. Macleods Pharms Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 108. Macleods Pharms Ltd Recent Developments
Table 109. Amneal Pharms Company Details
Table 110. Amneal Pharms Business Overview
Table 111. Amneal Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 112. Amneal Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 113. Amneal Pharms Recent Developments
Table 114. Apeloa Pharmaceutical Company Details
Table 115. Apeloa Pharmaceutical Business Overview
Table 116. Apeloa Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 117. Apeloa Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 118. Apeloa Pharmaceutical Recent Developments
Table 119. HUMANWELL GROUP Company Details
Table 120. HUMANWELL GROUP Business Overview
Table 121. HUMANWELL GROUP Memantine Hydrochloride Extended-Release Capsule Product
Table 122. HUMANWELL GROUP Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 123. HUMANWELL GROUP Recent Developments
Table 124. Eisai Co Company Details
Table 125. Eisai Co Business Overview
Table 126. Eisai Co Memantine Hydrochloride Extended-Release Capsule Product
Table 127. Eisai Co Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 128. Eisai Co Recent Developments
Table 129. Ono Pharmaceutical Co Ltd Company Details
Table 130. Ono Pharmaceutical Co Ltd Business Overview
Table 131. Ono Pharmaceutical Co Ltd Memantine Hydrochloride Extended-Release Capsule Product
Table 132. Ono Pharmaceutical Co Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 133. Ono Pharmaceutical Co Ltd Recent Developments
Table 134. Slate Run Company Details
Table 135. Slate Run Business Overview
Table 136. Slate Run Memantine Hydrochloride Extended-Release Capsule Product
Table 137. Slate Run Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022) & (US$ Million)
Table 138. Slate Run Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Type: 2021 VS 2028
Figure 2. 7mg Features
Figure 3. 14mg Features
Figure 4. 21mg Features
Figure 5. 28mg Features
Figure 6. Others Features
Figure 7. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Application: 2021 VS 2028
Figure 8. Home Case Studies
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Memantine Hydrochloride Extended-Release Capsule Report Years Considered
Figure 13. Global Memantine Hydrochloride Extended-Release Capsule Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Memantine Hydrochloride Extended-Release Capsule Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region: 2021 VS 2028
Figure 16. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Players in 2021
Figure 17. Global Top Memantine Hydrochloride Extended-Release Capsule Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Memantine Hydrochloride Extended-Release Capsule as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Memantine Hydrochloride Extended-Release Capsule Revenue in 2021
Figure 19. North America Memantine Hydrochloride Extended-Release Capsule Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Memantine Hydrochloride Extended-Release Capsule Market Size Market Share by Type (2017-2028)
Figure 21. North America Memantine Hydrochloride Extended-Release Capsule Market Size Market Share by Application (2017-2028)
Figure 22. North America Memantine Hydrochloride Extended-Release Capsule Market Size Share by Country (2017-2028)
Figure 23. United States Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Memantine Hydrochloride Extended-Release Capsule Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Memantine Hydrochloride Extended-Release Capsule Market Size Market Share by Type (2017-2028)
Figure 27. Europe Memantine Hydrochloride Extended-Release Capsule Market Size Market Share by Application (2017-2028)
Figure 28. Europe Memantine Hydrochloride Extended-Release Capsule Market Size Share by Country (2017-2028)
Figure 29. Germany Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Memantine Hydrochloride Extended-Release Capsule Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Memantine Hydrochloride Extended-Release Capsule Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Memantine Hydrochloride Extended-Release Capsule Market Size Share by Region (2017-2028)
Figure 39. China Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size Share by Country (2017-2028)
Figure 49. Mexico Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Memantine Hydrochloride Extended-Release Capsule Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Memantine Hydrochloride Extended-Release Capsule Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Memantine Hydrochloride Extended-Release Capsule Market Size Share by Country (2017-2028)
Figure 55. Turkey Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Lundbeck Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 59. Allergan Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 60. Novartis AG Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 61. Lupin Ltd Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 62. Huahai Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 63. Daiichi Sankyo Company Limited Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 64. Rottendorf Pharma GmbH Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 65. Polygen Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 66. Macleods Pharms Ltd Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 67. Amneal Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 68. Apeloa Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 69. HUMANWELL GROUP Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 70. Eisai Co Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 71. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 72. Slate Run Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed